Company / Current Liabilities per Share
ANI Pharmaceuticals, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$13.18
FY2025
5-year range
$6.12 / $13.18
FY2021-FY2025
Trend
+10.2%
vs FY2024
Sector context
#14 of 210
Health Care
What the data says
Among 210 Health Care companies, ANI Pharmaceuticals, Inc. is in the bottom 7% for current liabilities per share. Current Liabilities per Share has increased for 3 consecutive years, from $6.12 in FY2022 to $13.18 in FY2025.
Based on SEC 10-K filings.
13.18 in FY2025 with a 5-year CAGR of +14.9%. Top quartile in the Health Care sector.
Increased from $8.00 to $13.18 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +29.2%
- 5-Year CAGR
- +14.9%
- 10-Year CAGR
- -
Sector benchmark
-44.6% below sector average
Key checks
Key Insights
- ANI Pharmaceuticals, Inc.'s current liabilities per share has grown for 3 consecutive years.
- In FY2025, current liabilities per share increased 10.2% year-over-year.
- Ranks #14 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.18 | +10.2% |
| FY2024 | $11.96 | +49.6% |
| FY2023 | $8.00 | +30.7% |
| FY2022 | $6.12 | -12.0% |
| FY2021 | $6.95 | +5.8% |
| FY2020 | $6.57 | +22.9% |
| FY2019 | $5.34 | -62.0% |
| FY2018 | $14.06 | +314.3% |
| FY2017 | $3.39 | +23.0% |
| FY2016 | $2.76 | -99.9% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026